Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients

Abstract

Our previous study showed that elevated preoperative thyroglobulin (pre-Tg) level predicted the risk of developing radioiodine refractory in PTC patients. In the present study, we aimed to evaluate the prognostic value of pre-Tg in papillary thyroid microcarcinoma (PTMC). After a specific inclusion and exclusion criteria were applied, a total of 788 PTMCs were enrolled from Jiangyuan Hospital affiliated to Jiangsu Institute of Nuclear Medicine between Jan 2015 and Dec 2019. Among them, 107 PTMCs were treated with radioiodine therapy (RAIT) and the response to therapy was grouped as excellent response (ER), and non-excellent response (NER: indeterminate response, IDR and biochemical incomplete response, BIR). Multivariable logistic regression was used to identify predictors for the response of RAIT in PTMCs. Higher pre-Tg levels were detected in PTMCs with RAIT as compared with PTMCs without RAIT (p=0.0018). Higher levels of pre-Tg were also found in patients with repeated RAIT as compared with patients with single RAIT (p<0.0001). Furthermore, pre-Tg level was higher in PTMC with IDR (n=16) and much higher in BIR (n=9) as compared with patients with ER (n=82, p=0.0003) after RAIT. Multivariate analysis showed that pre-Tg level over 16.79 ng/ml [OR: 6.55 (2.10–20.39), p=0.001] was the only independent predictor for NER in PTMC with RAIT. We found that high level of pre-Tg predicted a poor RAIT outcome in PTMC. Our finding explores a prospective way in identifying high-risk PTMCs with poor response to RAIT.

Keywords

PTMC - preoperative thyroglobulin - radioiodine therapy - prognosis

Publication History

Received: 22 September 2023

Accepted after revision: 19 March 2024

Accepted Manuscript online:
19 March 2024

Article published online:
15 April 2024

• References

• 1 Lee JS, Lee JS, Yun HJ. et al. Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm. J Clin Endocrinol Metab 2023; 108: 1370-1375
• 2 Haugen BR, Alexander EK, Bible KC. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1-133
• 3 Sugitani I, Toda K, Yamada K. et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 2010; 34: 1222-1231
• 4 Ito Y, Miyauchi A, Kihara M. et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014; 24: 27-34
• 5 Baloch ZW, Asa SL, Barletta JA. et al. Overview of the 2022 who classification of thyroid neoplasms. Endocr Pathol 2022; 33: 27-63
• 6 Han B, Hao S, Wu J. et al. Predictive features of central lymph node metastasis in papillary thyroid microcarcinoma: roles of active surveillance in over-treatment. Front Med (Lausanne) 2022; 9: 906648
• 7 Citterio CE, Targovnik HM, Arvan P. The role of thyroglobulin in thyroid hormonogenesis. Nat Rev Endocrinol 2019; 15: 323-338
• 8 Huang Z, Song M, Wang S. et al. Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma. Ann Transl Med 2020; 8: 389
• 9 Kim H, Kim YN, Kim HI. et al. Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer. Sci Rep 2017; 7: 16955
• 10 Kim H, Park SY, Choe JH. et al. Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer. Cancers (Basel) 2020; 12: 625
• 11 Cheng X, Xu SC, Zhu Y. et al. Markedly elevated serum preoperative thyroglobulin predicts radioiodine-refractory thyroid cancer. Eur J Clin Invest 2021; 52: e13721
• 12 Brito JP, Ito Y, Miyauchi A. et al. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid 2016; 26: 144-149
• 13 Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the american joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2018; 68: 55-63
• 14 Petric R, Besic H, Besic N. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and hurthle cell neoplasms of the thyroid gland. World J Surg Oncol 2014; 12: 282
• 15 Oltmann SC, Leverson G, Lin SH. et al. Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden. J Surg Res 2014; 187: 1-5
• 16 Park JH, Choi M, Kim JH. et al. Metabolic syndrome and the risk of thyroid cancer: a nationwide population-based cohort study. Thyroid 2020; 30: 1496-1504
• 17 Walter LB, Scheffel RS, Zanella AB. et al. Active surveillance of differentiated thyroid cancer metastatic cervical lymph nodes: a retrospective single-center cohort study. Thyroid 2023; 33: 312-320
• 18 Chen Y, Sa R, Qiu X. et al. Second radioiodine treatment hardly benefits tt-dtc patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans. Q J Nucl Med Mol Imaging 2023; 67: 294-303
• 19 Yan L, Liu Y, Li W. et al. Long-term outcomes of ultrasound-guided thermal ablation for the treatment of solitary low-risk papillary thyroid microcarcinoma: a multicenter retrospective study. Ann Surg 2023; 277: 846-853
• 20 Hauch A, Al-Qurayshi Z, Randolph G. et al. Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons. Ann Surg Oncol 2014; 21: 3844-3852
• 21 Gao M, Ge M, Ji Q. et al. 2016 chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med 2017; 14: 203-211
• 22 Lee JS, Lee JS, Yun HJ. et al. Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm. J Clin Endocrinol Metab 2023; 108: 1370-1375
• 23 Piana S, Ragazzi M, Tallini G. et al. Papillary thyroid microcarcinoma with fatal outcome: Evidence of tumor progression in lymph node metastases: Report of 3 cases, with morphological and molecular analysis. Hum Pathol 2013; 44: 556-565
• 24 Wang Z, Guan H. Hear the patient's voice regarding implementation of thyroid cancer active surveillance in china. Thyroid 2023; 33: 782-784
• 25 Chang Q, Zhang J, Wang Y. et al. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis. Front Endocrinol (Lausanne) 2022; 13: 937049